Jushi (JUSHF) vs. Its Peers Head to Head Review

Jushi (OTCMKTS:JUSHF) is one of 511 publicly-traded companies in the “Healthcare Equipment & Supplies” industry, but how does it weigh in compared to its rivals? We will compare Jushi to similar companies based on the strength of its analyst recommendations, dividends, valuation, risk, earnings, profitability and institutional ownership.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Jushi and its rivals, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Jushi	0	0	1	0	3.00
Jushi Competitors	4291	10580	18364	831	2.46

As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 21.65%. Given Jushi’s rivals higher probable upside, analysts clearly believe Jushi has less favorable growth aspects than its rivals.

Insider & Institutional Ownership

21.7% of Jushi shares are owned by institutional investors. Comparatively, 40.5% of shares of all “Healthcare Equipment & Supplies” companies are owned by institutional investors. 23.1% of Jushi shares are owned by company insiders. Comparatively, 14.9% of shares of all “Healthcare Equipment & Supplies” companies are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Profitability

This table compares Jushi and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Jushi	-19.98%	N/A	-12.91%
Jushi Competitors	-304.20%	-315.07%	-22.11%

Risk & Volatility

Jushi has a beta of -0.61, indicating that its share price is 161% less volatile than the S&P 500. Comparatively, Jushi’s rivals have a beta of 2.57, indicating that their average share price is 157% more volatile than the S&P 500.

Valuation & Earnings

This table compares Jushi and its rivals revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Jushi	$262.91 million	-$68.59 million	-1.48
Jushi Competitors	$1.90 billion	$135.83 million	5.97

Jushi’s rivals have higher revenue and earnings than Jushi. Jushi is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Summary

Jushi rivals beat Jushi on 7 of the 13 factors compared.

Jushi Company Profile

Jushi Holdings Inc. is a vertically integrated cannabis company that develops, owns, and operates cannabis cultivation, processing, and retail businesses. The company offers medical and adult-use cannabis products where permitted by state law, including flower, pre-rolls, concentrates, edibles, vape products, and other cannabis-derived products. Jushi sells products through its portfolio of retail dispensaries and branded products, including the BEYOND/HELLO and The Apothecarium dispensary banners, as well as brands such as The Lab, Alchemy, and Seche.